Dengue Vaccines Market: Drivers, Restraints and Opportunities
- Get link
- X
- Other Apps
Dengue fever, often known as breakbone fever, is a viral virus transmitted by mosquitos that causes a severe flu-like disease. Severe dengue fever is a potentially fatal consequence of the disease. Dengue vaccine is a human vaccine that prevents dengue disease. Dengue vaccine is only indicated for people who have experienced dengue fever before. It is administered in three injections over the course of a year.
Global Dengue Vaccine Market: Drivers
Over the
forecast period, the worldwide
dengue vaccine market is expected to rise due to rising dengue
prevalence. According to the Pan American Health Organization, a total of
1,191,815 dengue cases were recorded in the Americas region, with 546,589 being
laboratory-confirmed and 5,599 being classed as severe dengue.
Dengue Vaccines Market |
Furthermore,
market expansion is likely to be aided by R&D of live attenuated vaccines.
Dengvaxia, for example, was licenced by the US Food and Drug Administration in
May 2019 for the prevention of dengue fever caused by all dengue virus
serotypes. It's a chimaera vaccine developed with recombinant DNA that's live
attenuated and tetravalent.
Global Dengue Vaccine Market:
Restraints
The market's
growth is projected to be hampered by the inability to distinguish dengue fever
from other febrile disorders. The symptoms of mosquito-borne infections like
Zika, chikungunya virus infection, and dengue fever, for example, are extremely
similar, making diagnosis challenging. Furthermore, the market's expansion is
projected to be hampered by a lack of understanding of the pathophysiology of
dengue infection and a lack of appropriate animal models.
Global Dengue Vaccine Market:
Opportunities
Dengue fever
cases are predicted to rise in metropolitan areas, providing lucrative growth
prospects for market players. In July 2018, researchers from the Bruno Kessler
Foundation's Center for Information Technology reported that the spread of
dengue fever in a non-endemic Brazilian metropolis was similar to a large dengue
epidemic in Cairns, Australia, where 95 percent of transmission events were
localised within the city. Changes in dengue age trends are also predicted to
promote market growth. For example, researchers from Taipei Medical University
revealed in February 2018 that the rate of dengue infection increased with age,
and that females over the age of 40 had a higher infection rate.
- Get link
- X
- Other Apps
Comments
Post a Comment